Hepatotoxicity, leucopenia and neutropenia associated with olanzapine therapy

International Journal of Psychiatry in Clinical Practice

Volumn 8, Issue 3, 2004, Pages 173-177

  Tchernichovsky, Eleonora ^b   Sirota, Pinkhas ^a  

^a ABARBANEL MENTAL HEALTH CENTER   (Israel)

^b NONE

Author keywords

Drug induced hepatitis; Leucopenia; Neutropenia; Olanzapine

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; LIVER ENZYME; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; CASE REPORT; DRUG WITHDRAWAL; FEMALE; FEVER; HEPATITIS; HUMAN; JAUNDICE; LEUKOCYTE COUNT; LEUKOPENIA; LIVER TOXICITY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

EID: 6044256151     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500410005577     Document Type: Review

References (37)

1. Mouradian-Stamatiadis L, Dumortier G, Januel D et al (2002) Liver function tests during treatment with antipsychotic drugs. A case series of 23 patients. Prog Neuro-Psychopharmacol Biol Psychiatry 26: 1409-11.
2. Hummer M, Kurz M, Kurzthaler I et al (1997) Hepatotoxicity of clozapine. J Clin Psychopharmacol 17 (4): 314-7.
3. Ishak K, Irey N (1972) Hepatic injury associated with the phenothiazines. Clinicophathologic and follow-up study of 36 patients. Arch Pathol 93: 283-304.
4. Beasley CM Jr, Tollefson G, Tran P et al (1996) Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trail. Neuropsychopharmacology 14: 111-23.
5. Cordeiro Q, Elkis (2001) Pancreatitis and cholestatic hepatitis induced by risperidone. J Clin Psychopharmacol 21(5): 529-30.
6. Casey DE (1997) The relationship of pharmacology to side effects. J Clin Psychiatry 58: 55-62.
7. Abdullah N, Voronovitch L, Taylor S et al (2003) Olanzapine and haloperidol: potential for neutropenia? Psychosomatics 44: 83-4.
8. Piscotta A (1978) Drug-induced agranulocytosis. Drugs 15: 132-43.
9. Levinson D, Simpson G (1987) Serious nonextrapyramidal adverse effects of neuroleptics: sudden death, agranulocytosis, and hepatotoxicity. In: Psychopharmacology, the Third Generation of Progress. New York: Raven Press.
10. Gaiwani P, Tesar G (2000) Case report. Olanzapine- induced neutropenia. Psychosomatics 41: 150-1.
11. DSM-4 (Diagnostic and Statistical Manual of Mental Disorders) (1993) American Psychiatric Ass., Washington, DC.
12. Dienstag JL, Wands JR, Isselbacher KJ (1991) Acute hepatitis. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK (eds) Harrison's Principles of Internal Medicine, vol. 2, 12th Edition. New York: McGraw-Hill: 1332-7.
13. Bauer M (1995) Concurrent agranulocytosis and acute hepatitis resulting from combination of classic neuroleptics and subsequent successful clozapine treatment: a case report. Pharmacopsychiatry 28: 29-31.
14. Mesotten E, Suy E, Pietquin M et al (1989) Therapeutic effect and safety of increasing doses of risperidone in psychotic patients. Psychopharmacology 99: 445-9.
15. Fuller M, Simon M, Freedman L (1996) Risperidone-associated hepatotoxicity. J Clin Psychopharmacol 16: 84-5.
16. Kumra S, Henon D, Jacobsen LK et al (1997) Case study: risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry 36 (5): 701-5.
17. Baldridge A, Peter-Atayde A, Graerne-Cook F et al (1995) Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 127: 700-4.
18. Cerulli TR (1997) Clozapine-associated pancreatitis. Harv Rev Psychiatry 7: 61-3.
19. Frankenburg FR, Kando J (1992) Eosinophilia, clozapine, and pancreatitis. Lancet 340: 251.
20. Martin A (1992) Acute pancreatitis associated with clozapine use. Am J Psychiatry 149: 714.
21. Jubert P, Fernandez R, Ruiz A et al (1994) Clozapine-related pancreatitis. Ann Intern Med 122: 397.
22. Raz A, Bergman R, Eilam O et al (2001) A case report of olanzapine-induced hypersensitivity syndrome. Am J Med Sci 321: 156-8.
23. Cadario B (2000) Olanzapine: suspected serious reactions. Can Med Assoc J 163: 85-6.
24. Selim K, Kaplowitz N (1999) Hepatotoxicity of psychotropic drugs. Hepatology 29: 1347-51.
25. Mayoral W, Lewis J (2000) Drugs-induced liver disease. Curr Opin Gastroenterol 16: 231-8.
26. Kodesh A, Finkel B, Lerner AG et al (2001) Dose-dependent olanzapine-associated leukopenia: three case reports. Int Clin Psychopharmacology 16: 117-9.
27. Hall RL, Smith AG, Edwards JG (2003) Hematological safety of antipsychotic drugs. Expect Opin Drug Saf 2: 395-9.
28. Pascoe SJ (2003) The adjunctive use of a centralized database in the monitoring clozapine-related neutropenia. Pharmacoepidemiol Drug Saf 12: 395-8.
29. Olanzapine/Clonazepam. Clinical Pharmacology. Monograph: Online Medical Database. Gold Standard Multimedia.
30. Steinwachs A, Grohmann R, Pedrosa F et al (1999) Two cases of olanzapine-induced reversible neutropenia. Pharmacopsychiatry 32 (4): 154-6.
31. Benedetti F, Cavallaro R, Smeraldi E (1999) Olanzapine-induced neutropenia after clozapine-induced neutropenia. Lancet 354 (9178): 567.
32. Beasley C, Tollefson G, Tran P (1997) Safety of olanzapine. J Clin Psychiatry 58: 13-7.
33. Fulton B, Goa K (1997) Olanzapine: a review, of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs 53: 281-98.
34. Meissner W, Schmidt T, Kupsch A et al (1999). Reversible leukopenia related to olanzapine. Movement Disorder 14 (5): 872-89.
35. Wray CM, Sztuke-Fournier A et al (1998) Olanzapine: hematological reactions. Can Med Assoc J 159(1): 80-2.
36. Schuld A, Kraus T, Hinze-Seich D et al (2000) Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Acta Psychiatr Scand 102: 153-5.
37. Buchman N, Strous R, Ulman A-M et al (2000) Olanzapine-induced leukopenia with human leukocyte antigen profiling. Int Clin Psychopharmol 16: 55-7.